查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439619

全球正壓氣動裝置市場：洞察、競爭格局、市場預測：2030 年

Positive Air Pressure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2020年全球正壓氣壓裝置市場規模為19.2億美元。 預計到 2030 年，該市場將達到 31.2 億美元，2024-2030 年預測期間複合年增長率為 8.40%。 正氣壓設備的需求主要受到阻塞性睡眠呼吸中止症盛行率上升、新生兒呼吸窘迫症候群盛行率上升、非侵入性通氣需求增加以及設備開發技術進步推動的成長。

由於睡眠呼吸中止症病例數量不斷增加，正壓設備市場預計在預測期內將大幅成長。 根據Bhatt 等人2020 年在《呼吸學》雜誌上發表的一篇題為“睡眠呼吸障礙的全球負擔及其影響”的論文，預計世界上超過七分之一的人口，即10 億人，將患有阻塞性呼吸病睡眠呼吸中止症。

本報告考察了全球正氣壓設備市場，並提供了市場概述，包括按設備類型、年齡組、最終用戶、地區以及進入市場的公司概況劃分的趨勢。

目錄

第1章正壓氣動裝置市場報告簡介

第 2 章正氣壓設備市場執行摘要

第3章監理與專利分析

  • 美國
  • 歐洲
  • 日本

第4章正壓氣動裝置市場主要因素分析

  • 推動正壓氣動設備市場的因素
  • 正壓氣動裝置市場的限制與挑戰
  • 積極的氣動設備市場機遇

第5章波特對正壓裝置市場的五力分析

第6章新型冠狀病毒肺炎（COVID-19）對正壓氣動裝置市場的影響分析

第7章正壓裝置市場概況

  • 依裝置類型
  • 依年齡段
  • 按最終用戶
  • 按地區

第8章全球正壓氣動裝置市場公司份額分析- 3至5家主要公司

第 9 章正壓氣動裝置市場公司與產品簡介

  • ResMed
  • Koninklijke Philips N.V
  • Fisher & Paykel Healthcare Limited
  • APEX MEDICAL CORP
  • ARMSTRONG MEDICAL (an EAKIN Company)
  • Smiths Medical
  • Compumedics Limited
  • VYAIRE MEDICAL, INC
  • Somnera Inc
  • 3B Medical Inc
  • DeVilbiss Healthcare LLC
  • Curative Medical Inc,
  • Somnetics International, Inc.
  • Lowenstein Medical UK Ltd.
  • Beijing Aeonmed Co., Ltd.
  • medin Medical Innovations GmbH
  • medicraft
  • Hebei Topson Medical Technology Ltd.
  • Sefam
  • Lowenstein Medical Technology GmbH + Co. KG

第 10 章專案方法

第11章KOL瀏覽量

第12章DelveInsight服務內容

第13章免責聲明

第 14 章關於 DelveInsight

Product Code: DIMDCL0453

Positive Airway Pressure Devices Market By Device Type (Continuous Positive Airway Pressure Devices, Autotitrating Poitive Airway Pressure Devices, And Bilevel Positive Airway Pressure Devices, And Others), By Age Group (Adults And Pediatrics), By End User (Hospitals, Clinics, And Homecare Settings), By Geography is expected to grow at a steady CAGR (forecast period-2024-2030) owing to rising prevalence of obstructive sleep apnea and increasing prevalence of neonatal respiratory distress syndrome

Global Positive Airway Pressure Devices Market was valued at USD 1.92 billion in 2020, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030. The demand for PAP Devices is primarily witnessing growth on account of the increasing prevalence of obstructive sleep apnea, rising prevalence of neonatal respiratory distress syndrome, growing demand for noninvasive ventilation, and technological advancements in device development.

Positive Airway Pressure Devices Market Dynamics:

The positive airway pressure devices market is set to experience a considerable growth in the forecast period due to the increasing number of cases of sleep apnea. As per the article published in the Journal "Respirology" titled "Global burden of sleep-disordered breathing and its implications" published in 2020 by Bhatt et al, it has been estimated that over one-seventh of the world's population or one billion are predicted to suffer from obstructive sleep apnea.

As per a research study published in the Lancet Journal titled "Estimation of the global prevalence and burden of obstructive sleep apnea: a literature-based analysis" by Benjafield et al, in 2019, it was estimated that 936 million adults aged 30-69 years (men and women) had mild to severe obstructive sleep apnea and 425 million (399-450) adults aged 30-69 years had moderate to severe obstructive sleep apnea globally. The number of affected individuals was highest in China, followed by the USA, Brazil, and India.

One of the major risk factors associated with OSA is obesity. As per the factsheet provided by the World Health Organization on Obesity (2023), the worldwide obesity has tripled since 1975. As per the same factsheet, in 2016, over 1.9 billion people overweight in 2016, of which 650 million people were obese. In 2020, 39 million children below the age of 5 were either obese or overweight. As being overweight increases the risk of numerous health implications, one of them being OSA, this could be a major influencing factor in the growing demand for PAP devices.

PAP devices help in keeping the airways open for sleep apnea patients and prevent it from collapsing while they sleep thereby enabling them to breathe normally.

Furthermore, another factor aiding in the growth of the PAP devices market is the rising number of cases of the neonatal respiratory distress syndrome. As per an article published in journal "Pharmacy & Therapeutics", titled "Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem" by Dyer (2019), the mortality rates associated with NRDS in poor countries are 10 times higher than wealthier countries. It further stated that the situation is not any better in wealthier countries as well, such as the United States where the mortality rates associated with NRDS reach as high as 60%.

Due to the drawbacks associated with mechanical ventilation, PAP devices are gaining popularity among end users in the treatment of infants suffering from NRDS.

Therefore, the abovementioned factors combined with others are expected to drive the growth of the PAP devices market.

However, frequent product recalls due to increasing risk of infections associated with PAP devices, may limit the positive airway pressure devices market growth over the forecast period.

Positive Airway Pressure Devices Market Segment Analysis:

Positive Airway Pressure Devices market by Device Type (Continuous Positive Airway Pressure Devices, Auto titrating Positive Airway Pressure Devices, Bilevel Positive Airway Pressure Devices, and Others), Positive Airway Pressure Devices market by Age Group (Adults and Pediatrics), Positive Airway Pressure Devices market by End User (Hospitals, Clinics, and Homecare Settings), and Positive Airway Pressure Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the PAP devices market, Continuous Positive Airway Pressure Devices are predicted to account for the largest market share compared to other device types. This can be attributed to the fact that CPAP devices are prescribed as the first line PAP therapy to patients. Another factor that adds to their popularity is the simplistic design of the device, which provides a steady pressure rate for both inhalation and exhalation. Furthermore, as CPAP devices have the most basic design and functionality, they cost significantly less than the counterparts, thereby contributing in their increased demand in the PAP devices market. Moreover, compared to other types of PAP devices, CPAP devices are covered by majority of the insurance providers which further add to their popularity among end users.

However, in the forecast period, Bilevel PAP devices are expected to witness the fastest growth in demand due to the rising requirement of different pressure rate PAP devices for inhalation and exhalation, addressing a drawback associated with CPAP devices.

North America is expected to dominate the overall Positive Airway Pressure Devices Market:

Among all the regions, North America is expected to account for the largest share in the PAP devices market. This can be attributed to the growing prevalence of OSA, obesity, diabetes and the well-established reimbursement programs in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

The North American PAP devices market is expected to witness growth due to rising prevalence of obesity in North American countries, particularly in the US. As per the facts provided by the Centers for Disease Control and Prevention (2023), the countrywide prevalence of obesity in 2017-2018 was 42.4%. It further stated that the prevalence of severe obesity increased to 9.2% in the same time period. Obesity is linked with many other indications such as heart disease, stroke, and a major risk factor for sleep apnea. Therefore, this increase in obesity prevalence may be a major contributing factor in the growing demand for PAP devices in the country, and subsequently in the North American region.

Furthermore, the supportive reimbursement structure for the PAP devices has also been instrumental in the active adoption of these devices by end users. Many of the insurance providers in the US provide coverage for PAP devices, majorly the CPAP devices.

Considering the presence of large patient pool in the country for OSA and obesity coupled with supportive reimbursement and insurance structure for PAP devices, the market for PAP devices is predicted to witness significant growth in the North American region.

Positive Airway Pressure Devices Market Key Players:

Some of the key market players operating in the PAP Devices market includes ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Lowenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Lowenstein Medical Technology GmbH + Co. KG and others.

RECENT DEVELOPMENTAL ACTIVITIES IN POSITIVE AIRWAY PRESSURE DEVICES MARKET:

In September 2022, Koninklijke Philips N.V received the authorization from the US Food and Drug Administration for the initiation of the repairing of their first-generation DreamStation CPAP devices. These devices were previously recalled in June 2022 due to probable health issues in patients.

In August 2022, ResMed launched AirSense 11 PAP Series, the company's next-generation PAP device for sleep apnea management. The device includes features such as Care-In and Personal Therapy Assistant among other features.

In February 2022, 3B Medical Inc received the product approval from US Food and Drug Administration for their new third generation bi-level device- Luna G3 Auto-BPAP device. The device is indicated to be used in the treatment of obstructive sleep apnea.

Key Takeaways from the Positive Airway Pressure Devices Market Report Study

  • Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Positive Airway Pressure Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the Global Positive Airway Pressure Devices Market.
  • Various opportunities available for the other competitor in the Positive Airway Pressure Devices Market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Global Positive Airway Pressure Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Global Positive Airway Pressure Devices market growth in the coming future?

Target Audience who can be benefited from this Positive Airway Pressure Devices Market Report Study

  • Positive Airway Pressure Devices providers
  • Research organizations and consulting companies
  • Positive Airway Pressure Devices-related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Positive Airway Pressure Devices
  • Various End-users who want to know more about the Positive Airway Pressure Devices Market and latest technological developments in the Positive Airway Pressure Devices market.

Frequently Asked Questions for Positive Airway Pressure Devices Market:

1. What is a Positive Airway Pressure Device?

PAP devices help in keeping the airways open for sleep apnea patients and prevent it from collapsing while they sleep thereby enabling them to breathe normally.

2. What is the market for Global Positive Airway Pressure Devices?

Global Positive Airway Pressure Devices Market was valued at USD 1.92 billion in 2020, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030.

3. What are the drivers for Global Positive Airway Pressure Devices Market?

The major drivers of the global positive airway pressure devices market growth are the increasing prevalence of obstructive sleep apnea, rising prevalence of neonatal respiratory distress syndrome, growing demand for non-invasive ventilation, and technological advancements in device development.

4. What are the key players operating in Global Positive Airway Pressure Devices Market?

Some of the major market players operating in the Positive Airway Pressure Devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Lowenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH,medicraft, Hebei Topson Medical Technology Ltd., Sefam, Lowenstein Medical Technology GmbH + Co. KG and others.

5. Which region has the highest share in Positive Airway Pressure Devices market?

North America is expected to dominate the overall Positive Airway Pressure Devices market during the forecast period, 2024 to 2030. This can be attributed to the growing prevalence of OSA, obesity, diabetes and the well-established reimbursement programs in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

Table of Contents

1.Positive Airway Pressure Devices Market Report Introduction

2. Positive Airway Pressure Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Positive Airway Pressure Devices Market Key Factors Analysis

  • 4.1. Positive Airway Pressure Devices Market Drivers
    • 4.1.1. Increasing Prevalence of Obstructive Sleep Apnea
    • 4.1.2. Growing Cases of Neonatal Respiratory Distress Syndrome
    • 4.1.3. Rising Demand for Non Invasive Ventilation
    • 4.1.4. Technological Advancements in Product Development
  • 4.2. Positive Airway Pressure Devices Market Restraints and Challenges
    • 4.2.1. Frequent Product Recalls
    • 4.2.2. Risks Associated with PAP Devices
  • 4.3. Positive Airway Pressure Devices Market Opportunities
    • 4.3.1. Improvement in Product Design and Safety

5. Positive Airway Pressure Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Positive Airway Pressure Devices Market

7. Positive Airway Pressure Devices Market Layout

  • 7.1. By Device Type
    • 7.1.1. CPAP Devices
    • 7.1.2. APAP Devices
    • 7.1.3. BiPAP Devices
    • 7.1.4. Others
  • 7.2. By Age Group
    • 7.2.1. Adults
    • 7.2.2. Pediatrics
    • 7.2.3. Others
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Homecare Settings
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America PAP Devices Market, by Types of Devices
      • 7.4.1.2. North America PAP Devices Market, by Age Group
      • 7.4.1.3. North America PAP Devices Market, by End User
      • 7.4.1.4. North America PAP Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe PAP Devices Market, by Types of Devices
      • 7.4.2.2. Europe PAP Devices Market, by Age Group
      • 7.4.2.3. Europe PAP Devices Market, by End User
      • 7.4.2.4. Europe PAP Devices Market, by Country
      • 7.4.2.2.1. France
      • 7.4.2.2.2. Germany
      • 7.4.2.2.3. United Kingdom
      • 7.4.2.2.4. Italy
      • 7.4.2.2.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific PAP Devices Market, by Types of Devices
      • 7.4.3.2. Asia-Pacific PAP Devices Market, by Age Group
      • 7.4.3.3. Asia-Pacific PAP Devices Market, by End User
      • 7.4.3.4. Asia-Pacific PAP Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW PAP Devices Market, by Types of Devices
      • 7.4.4.2. RoW PAP Devices Market, by Age Group
      • 7.4.4.3. RoW PAP Devices Market, by End User
      • 7.4.4.4. RoW PAP Devices Market, by Country
      • 7.4.4.3.1. Middle East
      • 7.4.4.3.2. Africa
      • 7.4.4.3.3. South America

8. Positive Airway Pressure Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Positive Airway Pressure Devices Market Company and Product Profiles

  • 9.1. ResMed
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Koninklijke Philips N.V
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Fisher & Paykel Healthcare Limited
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. APEX MEDICAL CORP
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. ARMSTRONG MEDICAL (an EAKIN Company)
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Smiths Medical
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Compumedics Limited
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. VYAIRE MEDICAL, INC
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Somnera Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. 3B Medical Inc
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. DeVilbiss Healthcare LLC
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Curative Medical Inc,
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Somnetics International, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Lowenstein Medical UK Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Beijing Aeonmed Co., Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. medin Medical Innovations GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. medicraft
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Hebei Topson Medical Technology Ltd.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Sefam
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Lowenstein Medical Technology GmbH + Co. KG
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Positive Airway Pressure Devices in Global (2018-2030)
  • Table 4: Positive Airway Pressure Devices in Global by Type of Devices (2018-2030)
  • Table 5: Positive Airway Pressure Devices in Global by Age Group (2018-2030)
  • Table 6: Positive Airway Pressure Devices in Global by End User (2018-2030)
  • Table 7: Positive Airway Pressure Devices in Global by Geography (2018-2030)
  • Table 8: Positive Airway Pressure Devices in North America (2018-2030)
  • Table 9: Positive Airway Pressure Devices in North America by Type of Devices (2018-2030)
  • Table 10: Positive Airway Pressure Devices in North America by Age Group (2018-2030)
  • Table 11: Positive Airway Pressure Devices in North America by End User (2018-2030)
  • Table 12: Positive Airway Pressure Devices in North America by Country (2018-2030)
  • Table 13: Positive Airway Pressure Devices in the US (2018-2030)
  • Table 14: Positive Airway Pressure Devices in Canada (2018-2030)
  • Table 15: Positive Airway Pressure Devices in Mexico (2018-2030)
  • Table 16: Positive Airway Pressure Devices in Europe (2018-2030)
  • Table 17: Positive Airway Pressure Devices in Europe by Type of Devices (2018-2030)
  • Table 18: Positive Airway Pressure Devices in Europe by Age Group (2018-2030)
  • Table 19: Positive Airway Pressure Devices in Europe by End User (2018-2030)
  • Table 20: Positive Airway Pressure Devices in Europe by Country (2018-2030)
  • Table 21: Positive Airway Pressure Devices in France (2018-2030)
  • Table 22: Positive Airway Pressure Devices in Germany (2018-2030)
  • Table 23: Positive Airway Pressure Devices in the United Kingdom (2018-2030)
  • Table 24: Positive Airway Pressure Devices in Italy (2018-2030)
  • Table 25: Positive Airway Pressure Devices in Spain (2018-2030)
  • Table 26: Positive Airway Pressure Devices in Russia (2018-2030)
  • Table 27: Positive Airway Pressure Devices in Rest of Europe (2018-2030)
  • Table 28: Positive Airway Pressure Devices in APAC (2018-2030)
  • Table 29: Positive Airway Pressure Devices in APAC by Type of Devices (2018-2030)
  • Table 30: Positive Airway Pressure Devices in APAC by Age Group (2018-2030)
  • Table 31: Positive Airway Pressure Devices in APAC by End User (2018-2030)
  • Table 32: Positive Airway Pressure Devices in APAC by Country (2018-2030)
  • Table 33: Positive Airway Pressure Devices in China (2018-2030)
  • Table 34: Positive Airway Pressure Devices in Japan (2018-2030)
  • Table 35: Positive Airway Pressure Devices in India (2018-2030)
  • Table 36: Positive Airway Pressure Devices in Australia (2018-2030)
  • Table 37: Positive Airway Pressure Devices in South Korea (2018-2030)
  • Table 38: Positive Airway Pressure Devices in Rest of APAC (2018-2030)
  • Table 39: Positive Airway Pressure Devices in Rest of World (2018-2030)
  • Table 40: Positive Airway Pressure Devices in RoW by Type of Devices (2018-2030)
  • Table 41: Positive Airway Pressure Devices in RoW by Age Group (2018-2030)
  • Table 42: Positive Airway Pressure Devices in RoW by End User (2018-2030)
  • Table 43: Positive Airway Pressure Devices in RoW by Region (2018-2030)
  • Table 44: Positive Airway Pressure Devices in Middle East (2018-2030)
  • Table 45: Positive Airway Pressure Devices in Africa (2018-2030)
  • Table 46: Positive Airway Pressure Devices in South America (2018-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis

Figures 3: Positive Airway Pressure Devices in Global (2018-2030)

Figures 4: Positive Airway Pressure Devices in Global by Type of Devices (2018-2030)

Figures 5: Positive Airway Pressure Devices in Global by Age Group (2018-2030)

Figures 6: Positive Airway Pressure Devices in Global by End User (2018-2030)

Figures 7: Positive Airway Pressure Devices in Global by Geography (2018-2030)

Figures 8: Positive Airway Pressure Devices in North America (2018-2030)

Figures 9: Positive Airway Pressure Devices in North America by Type of Devices (2018-2030)

Figures 10: Positive Airway Pressure Devices in North America by Age Group (2018-2030)

Figures 11: Positive Airway Pressure Devices in North America by End User (2018-2030)

Figures 12: Positive Airway Pressure Devices in North America by Country (2018-2030)

Figures 13: Positive Airway Pressure Devices in the US (2018-2030)

Figures 14: Positive Airway Pressure Devices in Canada (2018-2030)

Figures 15: Positive Airway Pressure Devices in Mexico (2018-2030)

Figures 16: Positive Airway Pressure Devices in Europe (2018-2030)

Figures 17: Positive Airway Pressure Devices in Europe by Type of Devices (2018-2030)

Figures 18: Positive Airway Pressure Devices in Europe by Age Group (2018-2030)

Figures 19: Positive Airway Pressure Devices in Europe by End User (2018-2030)

Figures 20: Positive Airway Pressure Devices in Europe by Country (2018-2030)

Figures 21: Positive Airway Pressure Devices in France (2018-2030)

Figures 22: Positive Airway Pressure Devices in Germany (2018-2030)

Figures 23: Positive Airway Pressure Devices in the United Kingdom (2018-2030)

Figures 24: Positive Airway Pressure Devices in Italy (2018-2030)

Figures 25: Positive Airway Pressure Devices in Spain (2018-2030)

Figures 26: Positive Airway Pressure Devices in Russia (2018-2030)

Figures 27: Positive Airway Pressure Devices in Rest of Europe (2018-2030)

Figures 28: Positive Airway Pressure Devices in APAC (2018-2030)

Figures 29: Positive Airway Pressure Devices in APAC by Type of Devices (2018-2030)

Figures 30: Positive Airway Pressure Devices in APAC by Age Group (2018-2030)

Figures 31: Positive Airway Pressure Devices in APAC by End User (2018-2030)

Figures 32: Positive Airway Pressure Devices in APAC by Country (2018-2030)

Figures 33: Positive Airway Pressure Devices in China (2018-2030)

Figures 34: Positive Airway Pressure Devices in Japan (2018-2030)

Figures 35: Positive Airway Pressure Devices in India (2018-2030)

Figures 36: Positive Airway Pressure Devices in Australia (2018-2030)

Figures 37: Positive Airway Pressure Devices in South Korea (2018-2030)

Figures 38: Positive Airway Pressure Devices in Rest of APAC (2018-2030)

Figures 39: Positive Airway Pressure Devices in Rest of World (2018-2030)

Figures 40: Positive Airway Pressure Devices in RoW by Type of Devices (2018-2030)

Figures 41: Positive Airway Pressure Devices in RoW by Age Group (2018-2030)

Figures 42: Positive Airway Pressure Devices in RoW by End User (2018-2030)

Figures 43: Positive Airway Pressure Devices in RoW by Region (2018-2030)

Figures 44: Positive Airway Pressure Devices in Middle East (2018-2030)

Figures 45: Positive Airway Pressure Devices in Africa (2018-2030)

Figures 46: Positive Airway Pressure Devices in South America (2018-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis